Complement activation has long been implicated in the pathogenesis of ALS, and many clinical and animal studies have shown that complement factors, including C1q and C3, have a strong upregulation in the dead regions of motor neurons (90). Here, C3 is linked to amyotrophic lateral sclerosis.